Lenalidomide Dr.Reddy's (Lenalidomide)

lenalidomide 25 mg capsule, 21 · ORAL · PBS code 12037M

AUTHORITY_REQUIRED

What it costs

AU$512.99 PBS-determined price per 21 units

Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.

• First listed on the PBS: 2023-02-01.
• Repeats: 1.
• PBS program: HS.

Eligibility criteria for subsidised access

The following is the government's own wording from the PBS Schedule, shown unchanged.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Multiple myeloma

Continuing treatment of triple therapy (this drug, bortezomib and dexamethasone) for treatment cycles 5 and 6 (administered using 28-day treatment cycles)

Patient must have received PBS-subsidised treatment with this drug under the treatment phase covering cycles 1 to 4; AND

The treatment must form part of triple combination therapy limited to: (i) this drug, (ii) bortezomib, (iii) dexamethasone; AND

The treatment must not exceed a total of 2 cycles under this restriction.

Sponsor: Dr Reddy's Laboratories (Australia) Pty Ltd ABN 16 120 092 408

Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.